HEAT INACTIVATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 (HIV-2)

被引：5
|
作者：
GREGERSEN, JP [1 ]
HILFENHAUS, J [1 ]
LEMP, JF [1 ]
机构：
[1] ELECTRO NUCLEON INC,INST CELL SCI,SILVER SPRING,MD 20904
来源：
JOURNAL OF BIOLOGICAL STANDARDIZATION | 1989年 / 17卷 / 04期
关键词：
D O I：
10.1016/S0092-1157(89)80009-5
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：377 / 379
页数：3
相关论文
共 50 条
  • [41] Serum immunoglobulin A (IgA)-mediated immunity in human immunodeficiency virus type 2 (HIV-2) infection
    Qin, LZ
    Skott, P
    Sourial, S
    Nilsson, C
    Andersson, S
    Ehnlund, M
    Taveira, N
    Björling, E
    VIROLOGY, 2003, 308 (02) : 225 - 232
  • [42] THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-2 (HIV-2) CONTAINS A NOVEL GENE ENCODING A 16-KD PROTEIN ASSOCIATED WITH MATURE VIRIONS
    FRANCHINI, G
    RUSCHE, JR
    OKEEFFE, TJ
    WONGSTAAL, F
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1988, 4 (04) : 243 - 250
  • [43] Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1
    Schramm, B
    Penn, ML
    Palacios, EH
    Grant, RM
    Kirchhoff, F
    Goldsmith, MA
    JOURNAL OF VIROLOGY, 2000, 74 (20) : 9594 - 9600
  • [44] INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
    MARKOVITZ, DM
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) : 211 - 218
  • [45] DRUG RESISTANCE MUTATIONS IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 (HIV-2) STRAINS FROM PATIENTS IN GHANA
    Abana, Christopher Zaab-Yen
    Sagoe, K. W. C.
    Bonney, E. Y.
    Maina, E. K.
    Aziati, I. D.
    Agbosu, E.
    Mawuli, G.
    Styer, L. M.
    Brandful, J. A. M.
    Ampofo, W. K.
    SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 : A91 - A92
  • [46] Quantitative real-time PCR on Lightcycler® for the detection of human immunodeficiency virus type 2 (HIV-2)
    Ruelle, J
    Mukadi, BK
    Schutten, M
    Goubau, P
    JOURNAL OF VIROLOGICAL METHODS, 2004, 117 (01) : 67 - 74
  • [47] Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
    Popper, SJ
    Sarr, AD
    Travers, KU
    Guèye-Ndiaye, A
    Mboup, S
    Essex, ME
    Kanki, PJ
    JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (04): : 1116 - 1121
  • [48] Requirements for RNA heterodimerization of the human immunodeficiency virus type 1 (HIV-1) and HIV-2 genomes
    Dirac, AMG
    Huthoff, H
    Kjems, J
    Berkhout, B
    JOURNAL OF GENERAL VIROLOGY, 2002, 83 : 2533 - 2542
  • [49] Potent Intratype Neutralizing Activity Distinguishes Human Immunodeficiency Virus Type 2 (HIV-2) from HIV-1
    Sahin, Gulsen Ozkaya
    Holmgren, Birgitta
    da Silva, Zacarias
    Nielsen, Jens
    Nowroozalizadeh, Salma
    Esbjornsson, Joakim
    Mansson, Fredrik
    Andersson, Soren
    Norrgren, Hans
    Aaby, Peter
    Jansson, Marianne
    Fenyo, Eva Maria
    JOURNAL OF VIROLOGY, 2012, 86 (02) : 961 - 971
  • [50] Inhibition of human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) by a new class of pyridine oxide derivatives
    Stevens, M
    Pannecouque, C
    De Clercq, E
    Balzarini, J
    ANTIVIRAL RESEARCH, 2002, 53 (03) : A42 - A42
12345